These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1021403)

  • 1. [Changes of the exocrine pancreatic function and results of secretin therapy in duodenal ulcer].
    Brailski VC; Mendisova A; Dimitrov B
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):245-7. PubMed ID: 1021403
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: A comparison of basal and stimulated gastric and pancreatic secretion in patients with and without duodenal ulcer disease.
    Gutierrez LV; Baron JH
    Gut; 1974 Oct; 15(10):836. PubMed ID: 4434957
    [No Abstract]   [Full Text] [Related]  

  • 3. The pancreatic exocrine secretion in duodenal ulcer patients before and after selective proximal vagotomy of the stomach.
    Berstad A; Roland M; Petersen H; Liaväg I
    Scand J Gastroenterol; 1974; 9(5):431-6. PubMed ID: 4854985
    [No Abstract]   [Full Text] [Related]  

  • 4. Secretin snuff: evaluation of the action on pentagastrin-stimulated gastric acid secretion and on pancreatic bicarbonate production.
    Halter F; Witzel L; Kohler B; Hadorn B
    Scand J Gastroenterol; 1975; 10(1):81-5. PubMed ID: 1168364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric secretion by exogenous secretin and cholecystokinin in normals and duodenal ulcer patients.
    Jörgensen SP; Henriksen FW
    Scand J Gastroenterol Suppl; 1976; 37():39-42. PubMed ID: 1064138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of duodenal ulcer with a long-acting synthetic secretin: a pilot trial.
    Demling L; Domschke W; Domschke S; Belohlavek D; Baenkler HW; Frühmorgen P; Lingenberg G; Wünsch E; Jaeger E
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):310-3. PubMed ID: 53980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by secretin of the gastric acid responses to meals and to pentagastrin in duodenal ulcer patients.
    Konturek SJ; Biernat J; Grzelec T
    Gut; 1973 Nov; 14(11):842-6. PubMed ID: 4761603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of atropine on stimulation by secretin of the pancreatic secretion in patients with duodenal ulcer].
    Geller LI; Glinskaia TP; Kozlova ZP
    Ter Arkh; 1976; 48(12):83-7. PubMed ID: 1013901
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Secretin release in man after intra-duodenal acid.
    Bloom SR; Ward AS
    Gut; 1974 Apr; 15(4):338. PubMed ID: 4834563
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to pentagastrin in man. II. Secretion of acid.
    Wormsley KG
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):150-8. PubMed ID: 4751156
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between gastric and pancreatic secretion in patients with duodenal ulcer.
    Petersen H
    Scand J Gastroenterol; 1970; 5(5):321-6. PubMed ID: 5455817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of calcitonin on gastric and pancreatic secretion and on the formation of experimental peptic ulcers in cats (author's transl)].
    Radecki T; Konturek SJ; Thor P; Demitrescu T; Pucher A
    Przegl Lek; 1974; 31(2):293-8. PubMed ID: 4831810
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of portacaval shunting on the exocrine pancreatic maximum secretory capacity.
    Ashikari H; Dreiling DA
    Am J Gastroenterol; 1968 Apr; 49(4):312-7. PubMed ID: 5650744
    [No Abstract]   [Full Text] [Related]  

  • 14. [The etiopathogenesis and therapy of gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1978 Sep; 86(6):515-35. PubMed ID: 367685
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous acid releases secretin in man.
    Domschke W; Greenberg GR; Domschke S; Bloom SR; Mitznegg P; Sprügel W; Demling L
    Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):262-3. PubMed ID: 930532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer concepts of pancreatic secretory patterns. Pancreatic secretory mass and pancreatic secretory capacity: pancreatic hypersecretion.
    Dreiling DA; Greenstein A; Bordalo O
    Mt Sinai J Med; 1973; 40(5):666-76. PubMed ID: 4542420
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies with a new anti-secretory drug (UK 5850) in rats and man.
    Hogbin BM; Cox SP; Johnson PA; Bugden RD; Bennett A; Pullman LG; Stevens EA
    Br J Surg; 1972 Nov; 59(11):902. PubMed ID: 4637104
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal effects of long-term treatment of duodenal ulcer with depot secretin: clinical, secretory, ultra-structural, and enzymological aspects.
    Demling L; Domschke W; Riemann JF; Domschke S; Ruppin H; Junge O; Wünsch E
    Scand J Gastroenterol Suppl; 1976; 42():136-45. PubMed ID: 796967
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of a new depot secretin on the gastric and pancreatic secretions in humans.
    Demling L; Classen M; Koch H; Domschke W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(4):324-30. PubMed ID: 4586496
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of secretin on gastric function in normal subjects and in patients with duodenal ulcer.
    Dalton MD; Eisenstein AM; Walsh JH; Fordtran JS
    Gastroenterology; 1976 Jul; 71(1):24-9. PubMed ID: 1278646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.